Natsoft vs Hexaware Patent case, Hexaware patent infringement

US Tech Firm Natsoft Drags Hexaware Into $500M Patent Fight

Hexaware Technologies, a leading Indian IT services company, is facing a massive $500 million lawsuit filed by US-based Natsoft Corporation and its subsidiary Updraft. Natsoft vs Hexaware patent case The case revolves around alleged contract violations and patent infringement, making it one of the biggest intellectual property rights (IPR) disputes in the IT sector. This […]

mRNA TALEN patent infringement case, mRNA technology patent case, Cellectis AstraZeneca patent dispute.

AstraZeneca Faces and Cellectis Inc. Patent Infringement Lawsuit by Factor Bioscience Over mRNA Gene-Editing Tech

A major patent dispute is making headlines in the pharmaceutical world, involving three big names in biotech and drug development.  mRNA TALEN patent infringement case Factor Bioscience Inc., a U.S.-based biotech company, has filed a patent infringement lawsuit against AstraZeneca PLC (a UK-based pharmaceutical giant) and Cellectis Inc. (a French-American biopharmaceutical firm). Factor Bioscience accuses […]

Protect invention, Protect invention from infringement

How an Invention Can Be Protected from Infringement?

In an innovation-driven economy, new ideas and inventions are being created all the time. But in the real world, inventors and investors don’t stop at just making something new — the bigger challenge lies in protect invention. So, we have prepared the full overview that any invention holder should follow to protect the invention, but […]

Wegovy Patent Case India, Natco Pharma vs Novo Nordisk

Wegovy (Semaglutide): Natco Pharma vs Novo Nordisk in Delhi High Court Over Weight-Loss Drug Wegovy

Another patent infringement fight over Wegovy (semaglutide) has reached the Delhi High Court. This time, the Wegovy Patent Case India is between two drugmakers from different parts of the world: Natco Pharma, the Hyderabad-based generics challenger, and Novo Nordisk, Natco Pharma Ltd, the Hyderabad-based generics manufacturer, filed a case against Novo Nordisk the Danish drugmaker, […]

Sun Pharma Leqselvi US launch, Leqselvi alopecia areata, Leqselvi deuruxolitinib

Sun Pharma Launches Leqselvi in U.S. After Patent Settlement—New Alopecia Areata Treatment Targets $900M Market

A major update is here—Sun Pharmaceutical Industries, one of India’s largest drugmakers, has officially launched its much-awaited hair loss treatment Leqselvi™ (deuruxolitinib) 8 mg tablets in the U.S. This launch comes after the settlement of a patent infringement case with Delaware-based Incyte Corporation. Sun Pharma Leqselvi US launch is expected to make waves in the […]